Immunology and Microbiology
Salmonella
100%
Cancer Cell
50%
Immunotherapy
50%
Mouse
45%
Immune Response
42%
Salmonella Enterica Serovar Typhimurium
42%
Immune System
40%
T Cell
35%
Immunosuppression
33%
T Cell Receptor
33%
CD154
33%
Wound Healing
25%
C3H/He Mouse
25%
Splenocyte
22%
Cytotoxicity
22%
Monospecific Antibody
21%
Cells of the Immune System
20%
Vaccine Efficacy
20%
Cancer Cell Line
19%
Interleukin-6
19%
Innate Immune System
18%
STAT3
18%
Interleukin 11
18%
T-Helper Cell
16%
Cell Cycle Progression
16%
Protein Family
16%
Bacterial Strain
16%
Intracellular Bacterium
16%
Borrelia burgdorferi
16%
Homeostasis
16%
Humoral Antibody
16%
Popliteal Lymph Node
16%
Lymphokine
16%
TLR Signaling
16%
STAT5
16%
CD4
16%
Cell Growth
16%
Sensitization
16%
Macrophage
16%
Pancreas
16%
Cancer Tissue
16%
Antiproliferative Activity
16%
Tumor Immunogenicity
16%
Myeloid Suppressor Cell
16%
Autoimmune Diabetes
16%
Immunity
16%
Immunoglobulin E
16%
CD43
16%
Autoantibodies
16%
Intravenous Immunoglobulin
16%
Serum Amyloid P Component
16%
Programmed Death-Ligand 1
16%
Candida
16%
Rivastigmine
16%
Gene Expression Assay
16%
Beta Chemokine
16%
Anaerobic Bacterium
16%
Antiinflammatory Activity
16%
Cell Cycle Arrest
16%
TFRC
16%
TLR4
16%
Combined Immunodeficiencies
16%
CD71 Antigen
16%
Lineages
12%
Cholinergic Anti-Inflammatory Pathway
12%
Immunosuppressive Drug
11%
Survival Rate
10%
Monoclonal Antibody
10%
Next Generation Sequencing
10%
Low Drug Dose
9%
Peritoneal Cavity
9%
Receptor Potential
9%
Gastrointestinal Epithelium
9%
Lck
8%
Immunofluorescence
8%
Spirochaete
8%
Outer Surface Protein A
8%
Oxidative Stress
8%
Tissue Level
8%
Major Histocompatibility Complex Peptide Complex
8%
Cytokine
8%
CD8
8%
Autoimmune Disease
8%
DNA Fragmentation
8%
Syngenic
8%
Bcl-2
8%
Allergen
8%
Turnaround Time
8%
Western Blot
8%
NLRP3 Inflammasome
8%
Cell Population
8%
Cell Infiltration
8%
Isotype
8%
Nervous System
8%
Peritoneal Exudate Cell
8%
Antimicrobial Immune Response
8%
MYD88
8%
Ganglion
8%
Cholinergic Activity
8%
Paneth Cell
8%
Keyphrases
Myeloid Differentiation Factor 88 (MyD88)
16%
Reciprocal Regulation
16%
CD4+ T Cells
16%
CD30 Expression
16%
CD30
16%
Interleukin-4 (IL-4)
16%
Differential Outcomes
16%
Attenuated Bacteria
16%
Immunotoxic Effect
16%
Immunomodulatory Effect
16%
NOD-like Receptor Protein 3 (NLRP3)
16%
Evidence-based Review
16%
Cytokine Expression
16%
Intracellular Bacteria
16%
Recombinant Strain
16%
Lyme Borreliosis
16%
Oral Vaccination
16%
OspA
16%
Borrelia Burgdorferi
16%
Epithelial Damage
16%
Modulation Characteristics
16%
Attenuated Salmonella
16%
Bioactive Characteristics
16%
Placebo-controlled Randomized Trial
16%
Novel Yeast Species
16%
Fruit Pomace
16%
Infectious Inflammation
16%
Spleen Cells
16%
Mitochondrial Modulator
16%
Peptide-MHC Complex
16%
Apparent Affinity
16%
Salmonella Vector
16%
Popliteal Lymph Node Assay
16%
Iosimenol
16%
Divergent Effects
16%
Acetylcholinesterase Inhibition
16%
Lethal Infection
16%
Immune System
16%
Immunomodulatory Response
16%
PMHC
16%
Family Protein
16%
Cell Cycle Progression
16%
Immunoexpression
16%
Ambrisentan
16%
Bioaccessible
16%
Receptor Complex
16%
T Cell Proliferation
16%
Biological Functionalities
16%
Untargeted Metabolomics
16%
T Cell Receptor
16%
Intravenous Administration
16%
Manuka Honey
16%
Liposomal Amphotericin B
16%
Hepatic Injury
16%
Farnesyl Pyrophosphate
16%
Dual Pathway
16%
Host Survival
16%
Inhibit Tumor
16%
Melanoma Mouse Model
16%
Subchronic
16%
Specific Immunoglobulin E
16%
CD43
16%
Type 2 Immune Response
16%
Truncation Variants
16%
Silver Nanoparticles
16%
Pentraxin 3 (PTX3)
16%
Innate Immune Pattern Recognition
16%
Neutropenic Fever
16%
D-glucan
16%
Bacterial Treatment
16%
Seed Polysaccharides
16%
Invasive Fungal Infection
16%
OX1R
16%
COVID-19 Response
16%
Systemic Inflammatory Response
16%
Th17 Effector Cells
16%
Yogurt-like
16%
M1-like
16%
Vaccine Effectiveness
16%
Toll-like Receptor 4 (TLR4)
16%
Anti-mannan
16%
Anti-mannan Antibody
16%
Invasive Candidiasis
16%
TCR Signaling
16%
P56lck
16%
Anti-PD-1 Monoclonal Antibody
16%
CD154
16%
Intestinal Barrier
16%
Patients with Hematological Malignancies
16%
Regulated on Activation
16%
Therapeutic Perspectives
16%
CARD11
16%
CXC Chemokines
16%
Prospective Observational Study
16%
Paternal Antigen
16%
Peripheral Neutrophils
16%
Birth-order Effect
16%
CD40 Ligand Deficiency
16%
Interaction Affinity
16%
Affinity Kinetics
16%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
77%
Neoplasm
57%
Tumor Growth
43%
Colorectal Carcinoma
41%
Flavonoid
33%
Transcriptome
33%
Mouse
28%
Chemotherapy
24%
Cancer Growth
22%
Adenoma
22%
Bacterial Infection
22%
Interleukin 11
22%
Salmonellosis
21%
Inflammation
20%
Salmonella
19%
Bacteremia
18%
Doxorubicin
16%
Randomized Controlled Trial
16%
Disease
16%
C3HeB/Fe Mouse
16%
Iosimenol
16%
Dimeric Nonionic Contrast Medium
16%
Ambrisentan
16%
Liver Injury
16%
Amphotericin B
16%
Melanoma
16%
Wound Healing
16%
Febrile Neutropenia
16%
Systemic Mycosis
16%
Glucan
16%
Ghrelin
16%
Protein Kinase Lck
16%
Placebo
16%
Intestine Flora
16%
Vaccine
16%
Mannan
16%
Beta Chemokine
16%
Sepsis
16%
Hematologic Malignancy
16%
Terpenoid
16%
Bone Infection
16%
Cholinergic Receptor Stimulating Agent
16%
Nuclear Factor
16%
Alternative Complement Pathway C3 C5 Convertase
16%
Carcinoma in Situ
16%
Adenocarcinoma
16%
Infection
15%
Paclitaxel
12%
Antiinfective Agent
12%
Paraoxon
11%
Infectious Agent
11%
Mecamylamine
11%
Septic Shock
11%
C3H/He Mouse
11%
Bacterial Clearance
11%
Biological Marker
10%
Deoxyuridine
9%
Coumarin Derivative
8%
Phytochemical
8%
Cell Viability
8%
Amino Acid
8%
Phenol
8%
Galacturonic Acid
8%
Blautia
8%
Ruminococcus
8%
Propionic Acid Derivative
8%
Butyric Acid Derivative
8%
Proteobacteria
8%
Firmicutes
8%
Cyclin A
8%
Protein Characterization
8%
Cyclic AMP Dependent Protein Kinase
8%
Complementary RNA
8%
Myeloid Differentiation Factor 88
8%
Cyclin B
8%
Pinocembrine
8%
Carboxylate
8%
Tumor Microenvironment
7%
Neutropenia
7%
Antibiotic as 48
6%
Osteomyelitis
6%
Cancer Staging
6%
Antifungal Therapy
6%
Carcinoma
6%
Immunogenicity
6%
Invasive Candidiasis
6%
Ileum
5%
Experimental Animal
5%
Liver Necrosis
5%
Leukemia
5%
Liver Cell Damage
5%
Caspase 6
5%
Salmonella Enterica Serovar Typhimurium
5%
Combination Therapy
5%
Cholinesterase Inhibitor
5%
Systemic Inflammatory Response Syndrome
5%
Candidiasis
5%
Colitis
5%
Aspergillosis
5%
Thrombocytopenia
5%
